ERBB2 and breast neoplasm: In our study, HER2 0 and HER2 1+ cases shared great similarities in terms of clinicopathologic features as well as HER2 mRNA expression, yet both were distinct from HER2 2+/FISH− cases, which may further indicate difficulty in accurate evaluation of HER2 0 and 1+ breast tumors.